Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
1,102.181,096.241,103.051,090.35
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
616.24616.24617.68609.10
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
1,189.721,194.741,202.791,188.58
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
1,725.691,730.021,762.991,730.02
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
643.62643.13643.17632.59
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
829.79832.32845.25832.32
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
213.40213.40216.07213.40
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
3,185.923,160.893,178.723,102.60
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
908.94912.57934.91912.57
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
1,478.961,478.171,482.911,466.65
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
2,405.362,390.342,402.532,359.18
302440:KRX
SK Bioscience Co Ltd
₩44,300.00
+0.34%
(+150.00) 1D
Apr 24, 3:30:12 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 302440...
Open
₩44,200
High
₩44,450
Low
₩43,950
Mkt. cap
3.48T
Avg. vol.
111.33K
Volume
55.89K
52-wk high
₩61,300
52-wk low
₩38,700
EPS
-₩733
Shares outstanding
78.46M
No. of employees
1K
News stories
From sources across the web
Profile
SK Bioscience is a South Korean biotechnology company that produces vaccines and other products and is a subsidiary of SK Chemicals. Wikipedia
About SK Bioscience Co Ltd
CEOAhn Jae-yong
Employees1.07K
FoundedJul 1, 2018
Headquarters-
SectorBiotechnology
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
154.56B
161.86B
150.76B
184.19B
Cost of goods sold
128.42B
150.33B
118.04B
179.39B
Cost of revenue
128.42B
150.33B
118.04B
179.39B
Research and development expenses
12.00B
20.24B
19.88B
17.75B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25.37B
24.53B
27.51B
33.59B
Operating expense
41.26B
48.92B
52.09B
56.40B
Total operating expenses
169.68B
199.25B
170.14B
235.80B
Operating income
-15.13B
-37.40B
-19.37B
-51.61B
Other non operating income
1.26B
3.46B
-637.92M
-1.13B
EBT including unusual items
-13.80B
-35.16B
-15.58B
-21.32B
EBT excluding unusual items
-18.85B
-36.71B
-23.07B
-48.65B
Income tax expense
-9.73B
-18.38B
-36.66B
35.09B
Effective tax rate
70.50%
52.28%
235.33%
-164.62%
Other operating expenses
146.94M
449.92M
281.98M
532.04M
Net income
-7.47B
-16.48B
24.48B
-57.96B
Net profit margin
-4.83%
-10.18%
16.24%
-31.47%
Earnings per share
-95.00
-210.00
313.00
-740.00
Interest and investment income
2.98B
3.14B
2.75B
6.81B
Interest expense
-2.42B
-2.28B
-2.67B
-2.04B
Net interest expenses
558.14M
859.12M
84.41M
4.77B
Depreciation and amortization charges
1.51B
1.48B
1.15B
1.49B
EBITDA
6.04B
-15.87B
3.25B
-25.91B
Gain or loss from assets sale
109.08M
371.46M
-547.83M
-30.91B
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more